Share ownership Terumo Corporation

4543

JP3546800008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 12:00:00 12/03/2026 pm IST			5-day change	1st Jan Change
2,044.50 ^JPY	-0.46%		+3.49%	-9.93%

02/03	Shoulder Innovations, Inc. Announces Board and Committee Changes, Effective February 26, 2026	CI
25/02	Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada	CI

Share class: Terumo Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	1,48,98,36,489	1,44,00,50,452 ( 96.66 %)	1,57,77,484 ( 1.059 %)	96.66 %

Major shareholders: Terumo Corporation

Name	Equities	%	Valuation
Amova Asset Management Co., Ltd. 4.2 %	6,21,80,200	4.2 %	840 M ¥
Meiji Yasuda Life Insurance Co. 3.234 %	4,78,84,000	3.234 %	647 M ¥
BlackRock Fund Advisors 3.114 %	4,61,06,408	3.114 %	623 M ¥
DAI-ICHI LIFE HOLDINGS, INC. 2.69 %	3,98,27,000	2.69 %	538 M ¥
BlackRock Japan Co. Ltd. 2.299 %	3,40,34,300	2.299 %	460 M ¥
Terumo Lifescience Foundation 1.988 %	2,94,40,000	1.988 %	398 M ¥
Mitsubishi UFJ Asset Management Co., Ltd. 1.97 %	2,91,65,400	1.97 %	394 M ¥
Mizuho Bank Pension Fund 1.18 %	1,74,72,000	1.18 %	236 M ¥
Dai Ichi Life Insurance Pension Fund 0.8105 %	1,20,00,000	0.8105 %	162 M ¥
Goldman Sachs Asset Management Co., Ltd. (Japan) 0.8012 %	1,18,61,852	0.8012 %	160 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Boston Common Asset Management LLC 0.001224 %	18,129	0.001224 %	245 013 ¥
RhumbLine Advisers LP 0.000905 %	13,393	0.000905 %	181 006 ¥
GAMMA Investing LLC 0.000167 %	2,474	0.000167 %	33 436 ¥
PNC Wealth Management LLC 0.000031 %	464	0.000031 %	6 271 ¥
Salomon & Ludwin LLC 0.000015 %	228	0.000015 %	3 081 ¥
Signature Equity Partners LLC 0.000012 %	179	0.000012 %	2 419 ¥
The Ameriflex Group, Inc. 0.000008 %	122	0.000008 %	1 649 ¥
Ancora Private Wealth Advisors LLC 0.000005 %	77	0.000005 %	1 041 ¥
IMA Advisory Services, Inc. 0.000004 %	60	0.000004 %	811 ¥
Thurston, Springer, Miller, Herd & Titak, Inc. 0 %	4	0 %	54 ¥

Breakdown by shareholder type

Institutional	16.21%
Other	7.28%
Dai-ichi Life Holdings, Inc.	2.69%
Terumo Corp.	0.37%
Medipal Holdings Corp.	0.15%
Yasuda Logistics Corp.	0.11%
SHIP HEALTHCARE HOLDINGS, INC.	0.09%
Mitsubishi Logistics Corp.	0.09%
Suzuken Co., Ltd.	0.08%
MEDIUS HOLDINGS Co., Ltd.	0.05%
Rengo Co., Ltd.	0.03%
Toho Holdings Co., Ltd.	0.02%
Yamashita Health Care Holdings, Inc.	0.02%
Tomoku Co., Ltd.	0.02%
Asahi Printing Co., Ltd.	0.01%
OLBA HEALTHCARE HOLDINGS, Inc.	0.01%
Unknown	72.77%

Based on 1000 largest holdings

Geographical origin of shareholders

Japan	20.96%
United States	3.39%
United Kingdom	1.36%
Sweden	0.36%
Netherlands	0.34%
Canada	0.25%
Switzerland	0.09%
Ireland	0.08%
Germany	0.06%
France	0.06%
Norway	0.05%
Denmark	0.04%
New Zealand	0.04%
Spain	0.03%
Finland	0.03%
Italy	0.02%
Luxembourg	0.02%
Hong Kong	0.01%
Singapore	0.01%
Austria	0.01%
Australia	0.01%

Based on 1000 largest holdings

Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.

Employees

30,591

Sector

Medical Equipment, Supplies & Distribution

Calendar

30/03 - Ex-dividend date - 15 JPY

More about the company